The Defence Materials Technology Centre (DMTC) is a not for profit collaborative venture that brings together defence industry, universities and government research agencies to develop technologies that will enhance Australia’s defence and national security capability.
The Medical Countermeasures (MCM) activity being hosted by DMTC is focused on vaccines, therapeutics and diagnostics for the protection of military and civilian personnel against Chemical Biological and Radiological (CBR) threats, emerging infectious diseases and pandemics.
Now closed, this call for Expressions of Interest for collaborative projects focused on three priority areas:
1. Point of Care Diagnostics
2. Antimicrobial Resistance and
3. Security Sensitive Biological Agents.
Proposed projects were required to have a minimum of one industry partner and one academic/research partner.
The DMTC MCM program is about translation of technology and therefore all proposed projects must be at or above the non-clinical/preclinical phase of development for vaccines and therapeutics; and a prototype for diagnostics.
The following guidance was provided to assist with applications:
– DMTC MCM EOI Information guide;
– DMTC MCM TRL Guide guide; and
– DMTC MCM Template QuadChart submission.
Quad Charts were required by no later than 1600hrs AEDT on Friday March 17, 2017. Further application rounds may be conducted in future. For more information please contact Felicia Pradera at DMTC on 03 9214 4447.Posted by DMTC on March 21st, 2017 Tagged: Countermeasures, EOI